Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 15 studies | 43% ± 21% | |
lung | 13 studies | 28% ± 15% | |
eye | 7 studies | 24% ± 9% | |
peripheral blood | 5 studies | 18% ± 2% | |
kidney | 5 studies | 20% ± 4% | |
adipose | 4 studies | 32% ± 9% | |
uterus | 3 studies | 30% ± 9% | |
breast | 3 studies | 22% ± 5% | |
prostate | 3 studies | 18% ± 3% | |
intestine | 3 studies | 19% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2821.14 | 1439 / 1445 | 100% | 59.60 | 183 / 183 |
lung | 100% | 4709.55 | 576 / 578 | 100% | 55.70 | 1152 / 1155 |
intestine | 100% | 2663.58 | 966 / 966 | 98% | 53.59 | 518 / 527 |
stomach | 98% | 2021.71 | 353 / 359 | 99% | 55.69 | 283 / 286 |
adrenal gland | 100% | 5698.59 | 258 / 258 | 94% | 42.34 | 216 / 230 |
uterus | 99% | 2313.34 | 168 / 170 | 95% | 43.86 | 434 / 459 |
kidney | 100% | 4659.08 | 89 / 89 | 92% | 28.51 | 825 / 901 |
ovary | 99% | 1725.74 | 179 / 180 | 92% | 20.97 | 396 / 430 |
bladder | 100% | 2580.52 | 21 / 21 | 87% | 31.83 | 440 / 504 |
breast | 100% | 4938.29 | 459 / 459 | 87% | 23.90 | 974 / 1118 |
brain | 98% | 3942.08 | 2586 / 2642 | 87% | 14.43 | 615 / 705 |
thymus | 100% | 2754.27 | 652 / 653 | 84% | 23.15 | 510 / 605 |
pancreas | 82% | 1186.75 | 270 / 328 | 99% | 33.23 | 176 / 178 |
skin | 97% | 1953.65 | 1752 / 1809 | 75% | 12.90 | 355 / 472 |
prostate | 96% | 2503.76 | 234 / 245 | 71% | 15.68 | 354 / 502 |
liver | 89% | 2245.39 | 202 / 226 | 66% | 14.76 | 269 / 406 |
adipose | 100% | 6271.42 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 2319.62 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.53 | 1 / 1 |
blood vessel | 100% | 2650.86 | 1331 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 37.81 | 42 / 45 |
lymph node | 0% | 0 | 0 / 0 | 83% | 13.71 | 24 / 29 |
heart | 71% | 1253.56 | 613 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 59% | 1329.00 | 544 / 929 | 0% | 0 | 0 / 0 |
muscle | 50% | 552.19 | 403 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 19% | 1.88 | 15 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1902083 | Biological process | negative regulation of peptidyl-cysteine S-nitrosylation |
GO_0006979 | Biological process | response to oxidative stress |
GO_1900408 | Biological process | negative regulation of cellular response to oxidative stress |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005634 | Cellular component | nucleus |
GO_0016922 | Molecular function | nuclear receptor binding |
GO_0030374 | Molecular function | nuclear receptor coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | NCOA7 |
Protein name | NCOA7-AS Nuclear receptor coactivator 7 (140 kDa estrogen receptor-associated protein) (Estrogen nuclear receptor coactivator 1) NCOA7 protein Nuclear receptor coactivator 7 |
Synonyms | ERAP140 ESNA1 Nbla10993 Nbla00052 |
Description | FUNCTION: Enhances the transcriptional activities of several nuclear receptors. Involved in the coactivation of different nuclear receptors, such as ESR1, THRB, PPARG and RARA. . |
Accessions | ENST00000453302.5 Q5TF98 Q8N4U9 ENST00000428318.1 Q5TF96 ENST00000444128.2 H0Y5F6 ENST00000392477.7 [Q8NI08-1] H0Y6T0 ENST00000417494.5 Q5TF97 Q6PK00 ENST00000419660.1 ENST00000438495.6 [Q8NI08-5] Q8NI08 ENST00000229634.13 [Q8NI08-7] ENST00000368357.7 [Q8NI08-1] |